DOJ’s 2026 Health Care Fraud Takedown Highlights Increased Coordination and Data-Driven Enforcement

This week, DOJ announced the results of its 2026 National Health Care Fraud Takedown, which involved charges against 455 defendants, including 90 medical professionals, in connection with alleged schemes involving more than $6.5 billion in false claims submitted to Medicare, Medicaid, and other federal health care programs.  The Takedown involved the participation of 50 state Medicaid Fraud Control Units and included cases in 56 federal districts and 45 U.S. states and territories.

The Takedown focused on several enforcement priorities, including alleged fraud involving patient harm arising from medically unnecessary services and services not rendered, opioid distribution, Medicare fraud involving wound care and allografts, Medicaid fraud, and schemes involving transnational criminal organizations.  While many of the charged matters involved traditional billing and kickback schemes, DOJ also highlighted several large, coordinated conspiracies that involved international cooperation and accounted for a significant portion of the alleged losses.  Those included the apprehension of a defendant in Kyrenia who was a member of a transnational criminal organization in connection with a $3.7 billion scheme for durable medical equipment that was never provided.  The Takedown also highlighted the recent apprehension in Estonia of two other defendants in the same transnational criminal organization who were charged in a $10.6 billion scheme.  Particularly notable—and a departure from past takedowns—is the volume of Medicaid matters.  Cases involving Medicaid account for 295 defendants and over $518 million in false claims.  Interestingly, this included a number of small-dollar cases with alleged losses under $10,000, including a case out of Louisiana involving just $5,532.95 in alleged fraudulent claims.

Across enforcement priorities, the 2026 announcement is noteworthy for what it reveals about the Department’s evolving enforcement strategy.  Beyond the headline numbers, the announcement reflects increasingly coordinated investigations that combine advanced data analytics and cross-agency and cross-border collaboration to identify and target complex health care fraud schemes.

Reliance on Data Analytics

The Takedown emphasizes that the federal government is “done playing catch-up,” to quote CMS Administrator Dr. Oz, and will increasingly rely on advanced data analytics to identify potentially fraudulent conduct earlier than traditional investigative methods might allow.  As an example, the Health Care Fraud Unit’s Data Analytics Team detected a more than four-fold spike in payment for allografts between 2023-2025, which led to multiple prosecutions highlighted in the Takedown, including that of a nurse practitioner who leveraged a $906 million scheme for medically unnecessary allografts to fund her purchase of luxury vehicles, jewelry, and even the construction of a multi-million dollar beach resort.

The newly established Health Care Fraud Unit’s Data Fusion Center appears to be a key component of this evolving strategy.  The Center builds upon pre-existing data analytics infrastructure and brings together experts from the Unit’s Data Analytics Team, HHS-OIG, FBI, and other agencies.  The Takedown announced the first prosecution arising from the Center’s Financial Intelligence Review Team, which combined traditional data analytics with financial analysis to identify claims submitted to Medicaid for more hours of behavioral health services than could have been provided in a single day.  Within days of the financial review, the Health Care Fraud Unit’s specialized prosecutors opened an investigation and only months later, the defendant was arrested when trying to flee the country.

The government appears poised to continue investing in its data analytics tools.  This week, the Fraud Division and CMS announced an agreement by which CMS will provide the Fraud Division with cloud computing space to allow it to “deploy advanced data analytics algorithms and artificial intelligence tools,” according to DOJ.

As DOJ expands its data analytics capabilities, health care companies, investors, and executives should continue to invest in robust compliance programs, internal auditing, and data-driven monitoring capable of identifying unusual billing and reimbursement patterns.

Coordinated Enforcement Efforts Across Agencies and Borders 

In addition to emphasizing its data analytics capabilities, DOJ labeled the Takedown “a new era in federal, state, and international cooperation to combat health care fraud.”

The announcement emphasizes increasing coordination across all levels of government.  At the federal level, the announcement highlights results from partnerships across many agencies, including the FBI, HHS-OIG, DEA, CMS, the Department of Veterans Affairs, Department of Labor, and others.  At the state level, the announcement credited 50 state Medicaid Fraud Control Units as participating, noting this is the most in Department history.

The announcement also reflects DOJ’s growing emphasis on international cooperation.  As an example, DOJ highlighted 29 defendants who were charged for their roles in a transnational criminal organization that allegedly submitted over $10 billion in fraudulent claims.  Several of those defendants were apprehended overseas and the Department thanked specific international governments for their cooperation.

The Takedown underscores the increasingly global nature of sophisticated health care fraud schemes and serves as a reminder for companies with international operations or partnerships that conduct harming the U.S. government is not out of reach for the government’s increasingly coordinated enforcement efforts.

Takeaways

In sum, the 2026 Takedown demonstrates that DOJ is not simply bringing more or larger health care fraud cases, but it is changing how those cases are identified and investigated.  Through increasingly sophisticated data analytics and enhanced coordination among domestic agencies and international enforcement partners, DOJ is building a more integrated enforcement model capable of moving quickly from identification to prosecution.  For companies participating in federal health care programs, investment in robust compliance programs, data analytics tools for internal monitoring, and prompt investigation of data anomalies remains critical as DOJ continues to refine its increasingly integrated enforcement model.

This post is as of the posting date stated above. Sidley Austin LLP assumes no duty to update this post or post about any subsequent developments having a bearing on this post.